Molecular imaging technology used in gastric cancerSeptember 25, 2008Modern cancer care is critically dependent on imaging technologies, which are used to detect early tumors and guide their therapy or surgery. Molecular imaging technologies provide information about the functional or metabolic characteristics of malignancies, tumor stage and therapeutical response, and tumor recurrence; whereas conventional imaging technologies predominantly assess the tumor's anatomical or morphologic features including its size, density, shape, etc. The research team led by Dr. Sun used PET/CT, which is based on information about the functional or metabolic characteristics of malignancies, to study the early recurrence in gastric cancer patients with suspected recurrence and in asymptomatic patients with gastric cancer. This will be published on Augest 7, 2008 in the World Journal of Gastroenterology address this question. PET/CT was positive in 14 patients and negative in 9 patients. When correlated with final diagnosis, which was confirmed by histopathologic evidence of tumor recurrence in 8 of the 23 patients and by clinical follow-up in 15. Overall, the accuracy of PET/CT was 82.6%, negative predictive value was 77.7%, and positive predictive value was 85.7%. Especially, PET/CT revealed true-positive findings in 47.8% patients who had negative or no definite findings by computed tomography. PET/CT demonstrated extra-abdomen metastasis in 7 patients and additional esophageal carcinoma in one patient. Clinical decisions of treatment were changed in 30.4% patients after introducing PET/CT into their conventional post-operative follow-up program.
These results demonstrate a new view of molecular imaging technology in gastric cancer, and thus may provide new application for further improving of the long term survival of patients who are suffering from gastric cancer. World Journal of Gastroenterology | |||||||||||||||||||||
|
Related Molecular Imaging Current Events and Molecular Imaging News Articles New breast imaging technology targets hard-to-detect cancers Breast-specific gamma imaging (BSGI) is effective in the detection of cancers not found on mammograms or by clinical exam, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). New imaging technique tracks cancer-killing cells over prolonged period Coaxing a patient's own cells to hunt down and tackle infected or diseased cells is a promising therapeutic approach for many disorders. Fibromyalgia can no longer be called the 'invisible' syndrome Using single photon emission computed tomography (SPECT), researchers in France were able to detect functional abnormalities in certain regions in the brains of patients diagnosed with fibromyalgia, reinforcing the idea that symptoms of the disorder are related to a dysfunction in those parts of the brain where pain is processed. New technique sees into tissue at greater depth, resolution By coupling a kicked-up version of microscopy with miniscule particles of gold, Duke University scientists are now able to peer so deep into living tissue that they can see molecules interacting. PET scans lead to treatment changes in majority of colorectal cancer patients In the largest multi-institutional study to date examining the impact of positron emission tomography (PET) in changing disease management of individuals with suspected recurrent colorectal cancer, researchers found that treatment plans were changed for more than half of patients. Fair and adequate reimbursement is vital to developing life-saving medical treatments Reimbursement of molecular imaging and therapies-leading to the early detection and diagnosis of many life-threatening diseases-remains an urgent and critical need as consumers face ever-increasing healthcare costs. Ability to track stem cells in tumors could advance cancer treatments Using noninvasive molecular imaging technology, a method has been developed to track the location and activity of mesenchymal stem cells (MSCs) in the tumors of living organisms. Molecular imaging sheds new light on progression of Alzheimer's disease In the past, physicians were able only to follow the progression of Alzheimer's disease (AD) through careful clinical histories, noting the often subtle changes associated with cognitive decline over a number of years. New possibilities for breast cancer treatment on the horizon he first patient scans from a custom-built scanner combining positron emission tomography (PET) and computed tomography (CT) technologies indicate that these scans could significantly improve breast cancer imaging capabilities and lead to more targeted treatment options, according to researchers at SNM's 55th Annual Meeting. First semiconductor-based PET scanner demonstrates potential to aid in early diagnosis of disease Evaluations of the first-ever prototype positron emission tomography (PET) brain scanner that uses semiconductor detectors indicate that the scanner could advance the quality and spatial resolution of PET imaging, according to researchers at SNM's 55th Annual Meeting. More Molecular Imaging Current Events and Molecular Imaging News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||